Selected article for: "major challenge and potential drug"

Author: Diaz, Natalia A.; Ambrosioni, Juan; Tuset, Montserrat; Brunet, Mercé; Cofan, Frederic; Crespo, Gonzalo; Ruiz, Pablo; Redondo-Pachón, Dolores; Crespo, Marta; Marín-Casino, Mónica; Moreno, Asunción; Miró, José M.
Title: Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review
  • Cord-id: z44vq1cr
  • Document date: 2021_4_8
  • ID: z44vq1cr
    Snippet: People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT represents a major challenge due to the potential drug-drug interactions between antiretroviral drugs and immunosuppressive agents, particularly when resorting to antiretroviral drugs that require pharmacokinetic enhancers. We report three cases of cobicistat-tacrolimus co-administration, two of which also include the co-administration of mTOR inhib
    Document: People living with HIV should be considered candidates for solid-organ transplantation (SOT). However, managing HIV-infected patients undergoing SOT represents a major challenge due to the potential drug-drug interactions between antiretroviral drugs and immunosuppressive agents, particularly when resorting to antiretroviral drugs that require pharmacokinetic enhancers. We report three cases of cobicistat-tacrolimus co-administration, two of which also include the co-administration of mTOR inhibitors, in HIV-positive patients undergoing SOT (2 kidney and 1 liver recipient). We review previously reported cases and provide recommendations for initial management following transplantation.

    Search related documents:
    Co phrase search for related documents